Cough News and Research

RSS

What is the viral rebound in untreated COVID-19 infections?

Researchers assessed the coronavirus disease 2019 (COVID-19) rebound in untreated COVID-19 infections.

4 Aug 2022

A combined influenza and COVID-19 mRNA vaccine

A combined mRNA vaccine is capable of inducing broad and durable protection against co-infection with SARS-CoV-2 and IAV,

3 Aug 2022

Further SARS-CoV-2 variants, and intermittent epidemics may become the 'new normal'

A new study explores the dynamics of the SARS-CoV-2 Omicron and other variants circulating in England.

2 Aug 2022

NUS study provides evidence of the cytotoxic effect of black cardamom on lung cancer cells

The main challenges associated with existing lung cancer drugs are severe side effects and drug resistance. There is hence a constant need to explore new molecules for improving the survival rate and quality of life of lung cancer patients.

1 Aug 2022

How and when do de novo SARS-CoV-2 spike mutations emerge?

Researchers evaluated viral mutations in two patients with persistent SARS-CoV-2 infection.

1 Aug 2022

RINVOQ® (upadacitinib) Approved by European Commission as an Oral Treatment for Adults with Active Non-Radiographic Axial Spondyloarthritis

With this approval, RINVOQ® is the first and only Janus Kinase inhibitor approved to treat patients across the spectrum of axial spondyloarthritis (nr-axSpA and ankylosing spondylitis) in the EU.

From AbbVie 29 Jul 2022

The effects of CBD in the treatment of COVID-19–related inflammatory symptoms

Researchers reviewed the effectiveness of cannabidiol in treating COVID-19 inflammatory-related symptoms.

28 Jul 2022

Face shields fail to provide high level of protection against COVID-19, finds study

If you wore a face shield during the pandemic, it probably didn't give you a high level of protection against Covid, according to new research from the University of East Anglia.

28 Jul 2022

UK study finds over 100 symptoms of long COVID in non-hospitalized adults

In a new study, researchers determined symptoms and risk factors present beyond 12 weeks in non-hospitalized adults with confirmed SARS-CoV-2 infection.

27 Jul 2022

Study confirms efficacy of molnupiravir against COVID in a real-life cohort

Researchers report the efficacy and safety of molnupiravir in treating COVID-19.

26 Jul 2022

CDC: Novavax's COVID-19 vaccine can be used as another primary series option for adults

Today, CDC Director Rochelle P. Walensky, M.D., M.P.H., endorsed the CDC Advisory Committee on Immunization Practices' (ACIP) recommendation that Novavax's COVID-19 vaccine be used as another primary series option for adults ages 18 years and older.

26 Jul 2022

Long-COVID is relatively infrequent, but still poses a threat

A new study suggests that long COVID complaints may not be common among COVID-19 patients as compared to the general population.

25 Jul 2022

COVID-19 related acute muscle loss linked to worse outcomes

Researchers investigate acute sarcopenia prevalence in COVID-19 patients and the outcomes of this complication.

25 Jul 2022

Appropriate guidance and follow-up needed for children at high risk for long COVID

Nearly 6 percent of children who presented to the Emergency Department (ED) with COVID-19 reported symptoms of long COVID 90 days later, according to a study conducted in eight countries and published in JAMA Network Open.

22 Jul 2022

Anti-SARS-CoV-2 nucleocapsid antibodies and pre-existing lung diseases may be independent predictors of long COVID

Researchers evaluated the incidence of long coronavirus disease (long COVID) in a demographically diverse population with different disease severities to inform clinicians and future vaccine development strategies.

21 Jul 2022

What is the association between natural killer cell dysfunction and COVID-19 disease severity?

Researchers assessed the association between natural killer cell dysfunction and COVID-19 disease severity.

20 Jul 2022

Survey explores the experiences of individuals with long COVID

Researchers explored the experiences of individuals with post-acute sequelae of COVID-19, also known as long COVID.

18 Jul 2022

Sore throat lozenges and sprays provide only a small reduction in throat pain

It's hard to get through a winter without suffering sore throat, but luckily they normally get better within a few days.

15 Jul 2022

Minimally invasive skin biopsy can help assess tissue damage related to SARS-CoV-2 infection

Using skin biopsy samples, investigators found that patients with severe COVID-19 had clots in small venous and arterial blood vessels in skin that appears normal.

14 Jul 2022

How do symptom burden and viral kinetics differ between healthy, vaccinated adults infected with either Delta, Omicron BA.1, or BA.2?

Researchers assessed the symptom profiles present in SARS-CoV-2 Delta, Omicron BA1. and BA.2-infected patients.

12 Jul 2022